We follow industry news and trends so you can stay ahead of the game. Subscribe to receive emails regarding policies and findings that impact you and your business.

Already a subscriber and want to update your preferences? Click here.

BACK TO NEWS

MEDIA MENTIONS

SEP 5 2019

J&J's $572M Fine in Oklahoma Opioid Case May Signal Lower Risk for Drugmakers – S&P Global Market Intelligence

Jason Parish, who is a Buchanan shareholder and part of the firm’s litigation section, was recently quoted in S&P Global Market Intelligence about how the $572 million fine Johnson & Johnson was ordered to pay will affect similar opioid litigation against pharmaceutical companies. Click here to read the article.